Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (HLN) covers the month of July 2025, specifically reporting on capital structure and voting rights as of June 30, 2025. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The company operates under Form 20-F for annual reporting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on share capital and voting rights.
- Total Shares Issued: 8,988,533,553 ordinary shares of £0.01 each.
- Treasury Shares: 3,880,205.
- Shares with Voting Rights: 8,984,653,348.
Material Changes
The filing does not disclose material changes in financial performance or operational metrics compared to prior periods. It serves as a notification of the current share count for regulatory compliance under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a procedural update regarding the denominator for calculating notifiable interests.
Key Facts for Investor Verification
- Verify the total number of voting shares (8,984,653,348) for accurate calculation of ownership thresholds.
- Confirm the number of treasury shares held (3,880,205) to understand the difference between issued and outstanding voting shares.
- Note that this filing does not contain financial performance data; refer to the most recent Form 20-F or quarterly reports for financial metrics.